VIEMED HEALTHCARE, INC. (VMD)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$204.2M
Stockholders' Equity
$144.0M
Cash & Equivalents
$10.7M
Long-Term Debt
$6.4M

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, VIEMED HEALTHCARE, INC. reported revenue of $78.1M, net income of $2.8M, and total assets of $204.2M. Every figure below is taken directly from VIEMED HEALTHCARE, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2018–FY2025 · as reported

$270.3M$138.3M$6.2M
FY2018FY2020FY2022FY2024FY2025
Revenue$270.3MNet income$14.9M
FY2018 revenue
$64.5M
FY2025 revenue
$270.3M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$270.3M$14.9M
FY2024$224.3M$11.3M
FY2023$183.0M$10.2M
FY2022$138.8M$6.2M
FY2021$117.1M$9.1M
FY2020$131.3M$31.5M
FY2019$80.3M$8.5M
FY2018$64.5M$9.5M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KAug 20, 2026on EDGAR ↗
8-KAug 3, 2026on EDGAR ↗
10-QAug 3, 2026on EDGAR ↗
8-KJun 4, 2026on EDGAR ↗
8-KJun 2, 2026on EDGAR ↗
8-KMay 5, 2026on EDGAR ↗
10-QMay 5, 2026on EDGAR ↗
DEF 14AApr 22, 2026on EDGAR ↗
8-KMar 16, 2026on EDGAR ↗
8-KMar 4, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$204.2Msource ↗
Stockholders’ Equity$144.0Msource ↗
Cash & Equivalents$10.7Msource ↗
Long-Term Debt$6.4Msource ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$78.1Msource ↗
Net Income$2.8Msource ↗
Operating Income$4.5Msource ↗
Gross Profit$45.0Msource ↗
Cost of Revenue$33.0Msource ↗
R&D Expense$504,000source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$0.07source ↗
EPS (basic)$0.07source ↗
Shares Outstanding38.1Msource ↗
Cash from Operations$15.9Msource ↗
Cash from Financing-$7.1Msource ↗
Cash from Investing-$7.8Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
6
Net shares
-30.0K

Restatement history

Point-in-time

2 of 338 annual fact-keys were materially restated between filings: what VIEMED HEALTHCARE, INC. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches VMD’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/VMD

MCP tool: get_sec_fundamentals ticker=VMD

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/VMD/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=VMD as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/VMD/history

MCP tool: get_fundamentals_history ticker=VMD

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/VMD

MCP tool: get_financial_health ticker=VMD

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.